NCT01634685 2020-08-20
A Phase I Study of Bavituximab, Capecitabine, and Radiation for the Treatment of Rectal Adenocarcinoma
University of Texas Southwestern Medical Center
Phase 1 Completed
University of Texas Southwestern Medical Center
UNC Lineberger Comprehensive Cancer Center
University of Arizona
Peregrine Pharmaceuticals